Alkeon Capital Management - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 128 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Alkeon Capital Management ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$39,549,453
+39.0%
1,725,1670.0%0.07%
+42.0%
Q2 2023$28,448,004
-20.9%
1,725,167
-14.4%
0.05%
-36.7%
Q1 2023$35,964,833
-44.8%
2,015,966
-9.9%
0.08%
-68.7%
Q4 2022$65,178,190
+56.0%
2,238,262
+31.3%
0.25%
+86.7%
Q3 2022$41,773,000
+571.1%
1,705,000
+13.7%
0.14%
+694.1%
Q2 2022$6,225,000
+756.3%
1,500,000
+5900.0%
0.02%
+325.0%
Q4 2017$727,00025,0000.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 2,075,000$47,569,3755.56%
NEA Management Company, LLC 2,909,956$66,710,7415.15%
Opaleye Management Inc. 653,000$14,970,0254.87%
Frazier Life Sciences Management, L.P. 2,371,304$54,362,1443.61%
VR Adviser, LLC 1,090,000$24,988,2502.63%
RA Capital Management 5,676,067$130,123,8362.56%
Samsara BioCapital, LLC 345,293$7,915,8422.42%
SILVERARC CAPITAL MANAGEMENT, LLC 260,537$5,972,8111.81%
Logos Global Management LP 400,000$9,170,0001.22%
Cormorant Asset Management, LP 850,000$19,486,2501.14%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders